Skip to content

Alexion Pharmaceuticals And Orphan Drug Soliris (Eculizumab)

October 29, 2012

        On October 24, 2012, Alexion Pharmaceuticals’ management discusses Q3 2012 results in an earnings call. 

         Per a Yahoo October 24, 2012 article, Alexion Pharmaceuticals says that “its net income climbed 41% in the Q3 2012 on greater sales of its orphan drug Soliris ……”. Soliris is Alexion Pharmaceuticals only marketed drug. Soliris is approved for the treatment in the US for Paroxysmal Nocturnal Hemoglobinuria (PNH) and aHUS.       

        Will Soliris’s new indication be for the treatment of severe relapsing NeuroMelitis Optica (NMO) ? 

         Alexion Pharmaceuticals announces October 9, 2012, that Phase 2 Study data is presented at the American Neurological Association (ANA) Annual meeting in Boston, Massachusetts. The Investigator-Initiated Phase 2 Study of Soliris (Eculizumab) in patients with severe relapsing Neuromyelitis Optica (NMO) met its primary efficacy endpoint with high degrees of clinical and statistical significance. 

        Per a HartfordBusiness.com article, “so far, Soliris has generated more than one billion dollars in sales for Alexion in its nearly five years on the market, and driven its stock recently to new 52-week highs. That success also has ushered in discussions around Wall Street and the global bioscience community about Alexion as a potential takeover target for one of the world’s big pharmas.” 

References 

Alexion Pharmaceuticals October 24, 2012 Press Release titled,”Alexion Reports 3rd Quarter 2012 Results”   

Orphan Druganaut October 10, 2012 Blog Post titled,”Does Alexion Pharmaceuticals’ Orphan Drug Soliris (Eculizumab) Have a New Rare Disease Indication ?“  

SeekingAlpha.com October 24, 2012 article titled,”Alexion Pharmaceuticals Management Discusses Q3 2012 Results – Earnings Call Transcript”  

Copyright  © 2012-2013, Ann-Teresa Cusenza and Orphan Druganaut Blog.  All rights reserved.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: